Liquid biopsy in breast cancer using NGS
9/10/20, 7:00 PM
NGS-based liquid biopsy assays combine an ultralow detection limit with broad genomic coverage and therefore offer a comprehensive testing strategy. However, the complexity of the wetlab process and the data processing have previously been challenging obstacles. In our webinar we will point out a possible approach on how to establish liquid biopsy in breast cancer using NGS.
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Clinical application of liquid biopsy in breast cancer, The new xgen Prism DNA Library Prep Kit, Validation of liquid biopsy: knowing your analytical performance
Simon von Ameln, Peter Verhasselt, Ben Liesfeld